ARTICLE | Company News
Myriad, PHA pharmacogenomics deal
October 30, 2001 8:00 AM UTC
MYGN will use its sequencing technologies to analyze various population samples to identify genetic polymorphisms in the general population. Pharmacia (PHA) and MYGN will explore commercialization of ...